Archive Newsletter
-
07.22.24 -- A Critical Analysis Of FDA Human Factors IFU Guidance For Drug Delivery Devices
7/22/2024
07/22/24 Drug Delivery Leader Newsletter
-
07.15.24 -- How The Right Operating Model For EU MDR Compliance Can Support A Global Footprint
7/15/2024
07/15/24 Drug Delivery Leader Newsletter
-
07.11.24 -- Frankly Fran: Embrace Packaging And Delivery Systems Designed For Today's Standards
7/11/2024
07/11/24 Drug Delivery Leader Newsletter
-
07.08.24 -- Integrating Risk Management With The Design Control Process
7/8/2024
07/08/24 Drug Delivery Leader Newsletter
-
07.01.24 -- Balancing Sustainability With Patient Safety In Medical Device Design
7/1/2024
07/01/24 Drug Delivery Leader Newsletter
- Best of June: Top 5 Insights In Drug Formulation and Delivery 6/27/2024
-
06.27.24 -- An Innovative Approach To Mitigate Nitrosamine Risks
6/27/2024
06/27/24 Drug Delivery Leader Newsletter
-
06.25.24 -- Ensure Success And Speed-To-Market With Drug Delivery Projects
6/25/2024
06/25/24 Drug Delivery Leader Newsletter
-
06.24.24 -- Long Live Design Controls: Navigating The Shift From QSR To QMSR
6/24/2024
06/24/24 Drug Delivery Leader Newsletter
-
06.17.24 -- Inside The FDA's New Draft Guidance On Data Integrity For In Vivo BA/BE Studies
6/17/2024
06/17/24 Drug Delivery Leader Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more